Stock Price
251.40
Daily Change
-49.60 -16.48%
Monthly
-36.68%
Yearly
-60.67%
Q1 Forecast
285.47

Novo Nordisk reported DKK17.44B in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Bausch Health Companies USD 801M 6M Dec/2025
Bristol-Myers Squibb USD 2.18B 392M Dec/2025
Eli Lilly USD 3.13B 391.3M Dec/2025
GlaxoSmithKline GBP 2.68B 518M Dec/2025
Merck USD 2.85B 215M Dec/2025
Novartis USD 3.31B 134M Sep/2025
Novo Nordisk DKK 17.44B 1.41B Dec/2025
Novo Nordisk DKK 2.86B 13.25B Jun/2025
Pacira USD 91.8M 14.6M Sep/2025
Sanofi EUR 2.75B 455M Dec/2025
Supernus Pharmaceuticals USD 179.68M 117.46M Sep/2025